Mesenchymal stem cell-derived exosomes: a new hope for improving asthma airway remodeling
This study emphasizes the advantages of MSC-EXOs as a therapeutic modality in the context of regenerative medicine for asthma treatment. Preclinical studies have consistently demonstrated the therapeutic potential of MSC-EXOs, suggesting that they may provide additional treatment options for asthma patients in the future.
Authors
- Xintao Du (ORCID: https://orcid.org/0009-0002-8542-9166)
- Jingjing Zhao (ORCID: https://orcid.org/0009-0005-0010-228X)
- Xiaoyun Zhao (ORCID: https://orcid.org/0000-0003-0873-7229)
- Ying Suo (ORCID: https://orcid.org/0009-0001-8805-2096)
- Tianxu Hao (ORCID: https://orcid.org/0009-0007-3268-4696)
- Rui Suo (ORCID: https://orcid.org/0009-0001-2641-1743)
- Ruxianguli Wumaier (ORCID: https://orcid.org/0009-0001-2975-6894)
Institutions
- Tianjin University (CN)
- Tianjin Chest Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1080/07853890.2025.2591447
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00